A detailed history of Darwin Advisors, LLC transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Darwin Advisors, LLC holds 25 shares of AVNS stock, worth $467. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Holding current value
$467
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$19.21 - $24.69 $480 - $617
25 New
25 $0
Q2 2020

Aug 06, 2020

SELL
$23.48 - $33.86 $587 - $846
-25 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$20.64 - $34.41 $516 - $860
25 New
25 $0

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $868M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.